Oxiquim Balance Sheet Health
Financial Health criteria checks 5/6
Oxiquim has a total shareholder equity of CLP110.0B and total debt of CLP54.0B, which brings its debt-to-equity ratio to 49.1%. Its total assets and total liabilities are CLP231.9B and CLP122.0B respectively. Oxiquim's EBIT is CLP32.4B making its interest coverage ratio -16.9. It has cash and short-term investments of CLP11.5B.
Key information
49.1%
Debt to equity ratio
CL$53.98b
Debt
| Interest coverage ratio | -16.9x |
| Cash | CL$11.55b |
| Equity | CL$109.96b |
| Total liabilities | CL$121.96b |
| Total assets | CL$231.92b |
Recent financial health updates
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Jun 10
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Feb 18Recent updates
Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down
May 25Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit
Apr 07Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Jun 10Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?
Apr 22Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down
Apr 01Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 11Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Feb 18Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?
Jan 27
Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?
Dec 28Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?
Dec 07Financial Position Analysis
Short Term Liabilities: OXIQUIM's short term assets (CLP73.9B) exceed its short term liabilities (CLP63.3B).
Long Term Liabilities: OXIQUIM's short term assets (CLP73.9B) exceed its long term liabilities (CLP58.7B).
Debt to Equity History and Analysis
Debt Level: OXIQUIM's net debt to equity ratio (38.6%) is considered satisfactory.
Reducing Debt: OXIQUIM's debt to equity ratio has increased from 41.9% to 49.1% over the past 5 years.
Debt Coverage: OXIQUIM's debt is well covered by operating cash flow (55.1%).
Interest Coverage: OXIQUIM earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 06:49 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oxiquim S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|